Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years

Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years

Blog Article

With the advent of new agents in the treatment of multiple sclerosis, new treatment modalities have emerged (escalation-induction therapy) and the increased efficacy of the drugs has led to increased johnny cash style clothing drug-related risks.The risk/benefit balance has become more carefully depileve easy clean assessed.The increased need for reliable markers to predict prognosis-disability has also led to an increase in research conducted in this area.In this short review, studies published between 2012-2017, especially those related to prognosis and disability, were compiled.